Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Strategic Vision with the Appointment of Andy Lindstrom as Director of Marketing

Sygnature Discovery has appointed Andy Lindstrom as Director of Marketing to develop and lead the marketing strategy for the business.

Andy holds a BA in Communications and Marketing from the University of Gävle, Sweden, an MA in Multimedia Journalism from the Universidad Europea, Spain, and an MBA from the University of Leicester.

Andy recently joined us from Siemens, where over 8 years he held roles including Head of Sales for Gas Networks, Marketing Manager for Siemens Managed Services and Communications Manager for the company’s Energy Sector. Prior to Siemens, he worked as a Communications Executive at Experian for over 2 years.

Reflecting on his appointment, Andy said:

“I saw the unique opportunity to grow with and help to grow an exciting, dynamic company with a high-quality offering in a fast-moving industry.

My position at Sygnature Discovery will involve setting-up a dedicated marketing function and establish a focused strategy to support the company’s ambitious growth plans. Furthermore, there is a need to develop and grow the Sygnature Discovery brand, in particular, outside of the United Kingdom, to ensure that our integrated drug discovery service-offering and expertise is better known and understood.”

Dr Paul Clewlow, Senior VP, Business Development, commented:

“We are delighted to welcome Andy to Sygnature and I am pleased to welcome him to my department.  We feel that the company will greatly benefit from the wealth of knowledge and strategic vision that he possesses as a marketeer.

Andy’s impressive experience in creating and executing effective marketing strategies will be vital as we aim to further expand our business and to reach out to new clients and new geographies.”

Latest News

View All

Sygnature Discovery announces multi-target drug discovery deal…

Dr. Scott Pollack – IDO Inhibitors and…

Dr. Scott Pollack – Intracellular Enzyme Inhibitors…

Dr. Scott Pollack – Ensuring Strong Hit-to-Lead…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.